These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37142131)

  • 21. NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease.
    Kalra PA; Bhandari S; Spyridon M; Davison R; Lawman S; Mikhail A; Reaich D; Pritchard N; McCafferty K; Moore J
    BMC Nephrol; 2020 Dec; 21(1):539. PubMed ID: 33302891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease.
    Schwenk MH
    Pharmacotherapy; 2010 Jan; 30(1):70-9. PubMed ID: 20030475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.
    Froessler B; Gajic T; Dekker G; Hodyl NA
    Arch Gynecol Obstet; 2018 Jul; 298(1):75-82. PubMed ID: 29740690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron deficiency in heart failure: a practical guide.
    Ebner N; von Haehling S
    Nutrients; 2013 Sep; 5(9):3730-9. PubMed ID: 24064572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial.
    Drexler C; Macher S; Lindenau I; Holter M; Moritz M; Stojakovic T; Pieber TR; Schlenke P; Amrein K
    Clin Nutr; 2020 Mar; 39(3):737-745. PubMed ID: 30981629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
    Khoury A; Pagan KA; Farland MZ
    Ann Pharmacother; 2021 Feb; 55(2):222-229. PubMed ID: 32633548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with Noripurum EV
    Venturieri MO; Komati JTS; Lopes LHC; Sdepanian VL
    Scand J Gastroenterol; 2019 Feb; 54(2):198-204. PubMed ID: 30782036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When is high-dose intravenous iron repletion needed? Assessing new treatment options.
    Gozzard D
    Drug Des Devel Ther; 2011 Jan; 5():51-60. PubMed ID: 21340038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom.
    Pollock RF; Muduma G
    J Med Econ; 2020 Jul; 23(7):751-759. PubMed ID: 32208038
    [No Abstract]   [Full Text] [Related]  

  • 30. Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.
    Fishbane S
    Semin Nephrol; 2016 Mar; 36(2):119-23. PubMed ID: 27236133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.
    Roger SD; Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Cronin M; Meier Y; Larroque S; Macdougall IC;
    Nephrol Dial Transplant; 2017 Sep; 32(9):1530-1539. PubMed ID: 28339831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In Vitro and In Vivo Evaluations of Mesoporous Iron Particles for Iron Bioavailability.
    Lin JF; Wu CC; Liao YJ; Jakfar S; Tang ZB; Chen JK; Lin FH
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB; Jaju PB
    BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
    Akin M; Atay E; Oztekin O; Karadeniz C; Karakus YT; Yilmaz B; Erdogan F
    Pediatr Hematol Oncol; 2014 Feb; 31(1):57-61. PubMed ID: 24087940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferumoxytol for the treatment of iron deficiency anemia.
    Auerbach M; Chertow GM; Rosner M
    Expert Rev Hematol; 2018 Oct; 11(10):829-834. PubMed ID: 30188740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.
    Basha A; Ibrahim MIM; Hamad A; Chandra P; Omar NE; Abdullah MAJ; Aldapt MB; Hussein RM; Mahfouz A; Adel AA; Shwaylia HM; Ekeibed Y; AbuMousa R; Yassin MA
    PLoS One; 2021; 16(8):e0255104. PubMed ID: 34375369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease and anemia: intravenous iron treatment.
    Kangaspunta M; Haapamäki J; Färkkilä M; Arkkila P
    Scand J Gastroenterol; 2018 Apr; 53(4):430-434. PubMed ID: 29468908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency.
    Macdougall IC; Comin-Colet J; Breymann C; Spahn DR; Koutroubakis IE
    Adv Ther; 2020 May; 37(5):1960-2002. PubMed ID: 32297281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.
    Ozsahin H; Schaeppi M; Bernimoulin M; Allard M; Guidard C; van den Ouweland F
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28614. PubMed ID: 32729200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis.
    Sultan P; Bampoe S; Shah R; Guo N; Estes J; Stave C; Goodnough LT; Halpern S; Butwick AJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):19-29.e3. PubMed ID: 30578747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.